Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vikram Mathews

Showing results (181-190 of 216) with videos related to

Pageof 22
Sort By:
Oncotarget|September 18, 2015
DNA-mediated adjuvant immunotherapy extends survival in two different mouse models of myeloid malignanciesCarole Le Pogam, Satyananda Patel, Petra Gorombei, et al.
Cell Death & Disease|November 4, 2025
A novel strategy to target metabolic dependencies in acute myeloid leukemiaNithya Balasundaram, Hamenth Kumar Palani, Arvind Venkatraman, et al.
Molecular Therapy. Oncology|April 18, 2025
Safety, efficacy and total cost of point-of-care manufactured anti-CD19 CAR-T cell therapy in India: VELCART trialHamenth Kumar Palani, Arun Kumar Arunachalam, Uday Kulkarni, et al.
Frontiers in Immunology|July 3, 2018
Arsenic Trioxide Enhances the NK Cell Cytotoxicity Against Acute Promyelocytic Leukemia While Simultaneously Inhibiting Its Bio-GenesisAnsu Abu Alex, Saravanan Ganesan, Hamenth Kumar Palani, et al.
Bone & Joint Open|March 23, 2025
Evaluation of safety and efficacy of multiple intravenous and intraosseous doses of foetal liver-derived mesenchymal stem cells in children with severe osteogenesis imperfecta : the BOOST2B clinical trial protocolVrisha Madhuri, Sowmya Ramesh, Annika Goos, et al.
Pharmacogenomics and Personalized Medicine|October 11, 2021
<i>NUDT15</i> c.415C>T Polymorphism Predicts 6-MP Induced Early Myelotoxicity in Patients with Acute Lymphoblastic Leukemia Undergoing Maintenance TherapyAswin Anand Pai, Ajith Mohan, Esther Sathya Bama Benjamin, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|March 12, 2020
A Prospective Observational Multi-institutional Study on Invasive Fungal Infections Following Chemotherapy for Acute Myeloid Leukemia (MISFIC Study): A Real World Scenario from IndiaBiju George, Hari Menon, Dinesh Bhurani, et al.
Blood Advances|September 1, 2019
Related and unrelated donor transplantation for β-thalassemia major: results of an international surveyChunfu Li, Vikram Mathews, Soyoung Kim, et al.
Clinical Pharmacology and Therapeutics|October 17, 2023
Treosulfan Exposure Predicts Thalassemia-Free Survival in Patients with Beta Thalassemia Major Undergoing Allogeneic Hematopoietic Cell TransplantationAswin Anand Pai, Ezhilpavai Mohanan, John C Panetta, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|April 27, 2026
Best Practices for Thalassaemia Management: Recommendations by Indian Society of Haematology and Blood TransfusionTuphan Kanti Dolai, Rabindra Kumar Jena, Shipla Roy, et al.
Pageof 22

Showing results (181-190 of 216) with videos related to

Sort By:
Pageof 22
Oncotarget|September 18, 2015
DNA-mediated adjuvant immunotherapy extends survival in two different mouse models of myeloid malignanciesCarole Le Pogam, Satyananda Patel, Petra Gorombei, et al.
Cell Death & Disease|November 4, 2025
A novel strategy to target metabolic dependencies in acute myeloid leukemiaNithya Balasundaram, Hamenth Kumar Palani, Arvind Venkatraman, et al.
Molecular Therapy. Oncology|April 18, 2025
Safety, efficacy and total cost of point-of-care manufactured anti-CD19 CAR-T cell therapy in India: VELCART trialHamenth Kumar Palani, Arun Kumar Arunachalam, Uday Kulkarni, et al.
Frontiers in Immunology|July 3, 2018
Arsenic Trioxide Enhances the NK Cell Cytotoxicity Against Acute Promyelocytic Leukemia While Simultaneously Inhibiting Its Bio-GenesisAnsu Abu Alex, Saravanan Ganesan, Hamenth Kumar Palani, et al.
Bone & Joint Open|March 23, 2025
Evaluation of safety and efficacy of multiple intravenous and intraosseous doses of foetal liver-derived mesenchymal stem cells in children with severe osteogenesis imperfecta : the BOOST2B clinical trial protocolVrisha Madhuri, Sowmya Ramesh, Annika Goos, et al.
Pharmacogenomics and Personalized Medicine|October 11, 2021
<i>NUDT15</i> c.415C>T Polymorphism Predicts 6-MP Induced Early Myelotoxicity in Patients with Acute Lymphoblastic Leukemia Undergoing Maintenance TherapyAswin Anand Pai, Ajith Mohan, Esther Sathya Bama Benjamin, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|March 12, 2020
A Prospective Observational Multi-institutional Study on Invasive Fungal Infections Following Chemotherapy for Acute Myeloid Leukemia (MISFIC Study): A Real World Scenario from IndiaBiju George, Hari Menon, Dinesh Bhurani, et al.
Blood Advances|September 1, 2019
Related and unrelated donor transplantation for β-thalassemia major: results of an international surveyChunfu Li, Vikram Mathews, Soyoung Kim, et al.
Clinical Pharmacology and Therapeutics|October 17, 2023
Treosulfan Exposure Predicts Thalassemia-Free Survival in Patients with Beta Thalassemia Major Undergoing Allogeneic Hematopoietic Cell TransplantationAswin Anand Pai, Ezhilpavai Mohanan, John C Panetta, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|April 27, 2026
Best Practices for Thalassaemia Management: Recommendations by Indian Society of Haematology and Blood TransfusionTuphan Kanti Dolai, Rabindra Kumar Jena, Shipla Roy, et al.
Pageof 22